IRIS PubliCatt

Dragonetti, Giulia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 474
EU - Europa 283
AS - Asia 105
SA - Sud America 4
AF - Africa 2
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 1
Totale 871
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 472
SE - Svezia 104
IT - Italia 49
IE - Irlanda 40
SG - Singapore 36
ID - Indonesia 27
CN - Cina 26
DE - Germania 25
FR - Francia 22
RU - Federazione Russa 15
FI - Finlandia 6
ES - Italia 5
IN - India 4
TR - Turchia 4
CH - Svizzera 3
CZ - Repubblica Ceca 3
GB - Regno Unito 3
BE - Belgio 2
BR - Brasile 2
EU - Europa 2
HK - Hong Kong 2
IL - Israele 2
TW - Taiwan 2
UA - Ucraina 2
AU - Australia 1
BG - Bulgaria 1
CA - Canada 1
CI - Costa d'Avorio 1
CL - Cile 1
CO - Colombia 1
JP - Giappone 1
MX - Messico 1
MY - Malesia 1
NL - Olanda 1
RO - Romania 1
RS - Serbia 1
SC - Seychelles 1
Totale 871
Salva come PNG Salva come JPEG
Città #
Chandler 134
Ashburn 76
Dublin 40
Chicago 28
Jakarta 27
Singapore 23
Marseille 19
Beijing 16
New York 15
Bremen 14
Princeton 14
Boston 13
Milan 13
San Mateo 13
Washington 13
Moscow 10
Rome 7
Wilmington 7
Los Angeles 6
Ann Arbor 4
Falls Church 4
Brno 3
Busto Arsizio 3
Cattolica 3
Dearborn 3
Helsinki 3
Lappeenranta 3
London 3
Nanjing 3
Santa Clara 3
Valladolid 3
Augusta 2
Bern 2
Brussels 2
Como 2
Hong Kong 2
Madrid 2
Munich 2
Paris 2
Parma 2
Perugia 2
Pune 2
São Paulo 2
Abidjan 1
Alameda 1
Andover 1
Boardman 1
Cambridge 1
Cavalese 1
Clifton 1
Esslingen am Neckar 1
Fairfield 1
Falkenstein 1
Florence 1
Forest City 1
Frankfurt am Main 1
Groningen 1
Gunzenhausen 1
Hebei 1
Izmir 1
Jiaxing 1
Kaohsiung 1
Kuala Lumpur 1
Latiano 1
Leawood 1
Logan 1
Medellín 1
Mexico City 1
Moldova Noua 1
Montreal 1
Mumbai 1
Nanchang 1
Niš 1
Novokuznetsk 1
Nuremberg 1
Redmond 1
Redwood City 1
Seattle 1
Sofia 1
Taipei 1
Tivoli 1
Zurich 1
Totale 589
Salva come PNG Salva come JPEG
Nome #
Treatment of primary plasma cell leukemia with high doses of cyclophosphamide, bortezomib, and dexamethasone followed by double autologous HSCT 82
Candidaemia in haematological malignancy patients from a SEIFEM study: Epidemiological patterns according to antifungal prophylaxis 63
'Real-life' analysis of the role of antifungal prophylaxis in preventing invasive aspergillosis in AML patients undergoing consolidation therapy: Sorveglianza Epidemiologica Infezioni nelle Emopatie (SEIFEM) 2016 study 61
Invasive aspergillosis in relapsed/refractory acute myeloid leukaemia patients: Results from SEIFEM 2016-B survey 55
Developments in identifying and managing mucormycosis in hematologic cancer patients 49
COVID-19 in vaccinated adult patients with hematological malignancies: preliminary results from EPICOVIDEHA 48
Rhodotorula infection in haematological patient: Risk factors and outcome 46
Rhodotorula infection in haematological patient: Risk factors and outcome 46
Extramedullary Involvement in Acute Myeloid Leukemia. A Single Center Ten Years' Experience 46
COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA) 45
Invasive aspergillosis in relapsed/refractory acute myeloid leukaemia patients: Results from SEIFEM 2016-B survey 43
Impact of invasive aspergillosis occurring during first induction therapy on outcome of acute myeloid leukaemia (SEIFEM-12B study) 42
Disseminated geosmithia argillacea infection in a patient with ph-positive acute lymphoblastic leukemia. Case report and literature review 38
Pharyngeal microbial signatures are predictive of the risk of fungal pneumonia in hematologic patients 36
Nirmatrelvir/ritonavir in COVID-19 patients with haematological malignancies: a report from the EPICOVIDEHA registry 34
COVID-19 in adult acute myeloid leukemia patients: a long-term follow-up study from the European Hematology Association survey (EPICOVIDEHA) 27
A High-Risk Profile for Invasive Fungal Infections Is Associated with Altered Nasal Microbiota and Niche Determinants 22
Prospective multicenter study on infectious complications and clinical outcome of 230 unfit acute myeloid leukemia patients receiving first-line therapy with hypomethylating agents alone or in combination with Venetoclax 19
Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: results from the EPICOVIDEHA survey 17
Outcome of infection with omicron SARS-CoV-2 variant in patients with hematological malignancies: An EPICOVIDEHA survey report 14
Simultaneous Onset of Haematological Malignancy and COVID: An Epicovideha Survey 14
Outcomes of SARS-CoV-2 infection in Ph-neg chronic myeloproliferative neoplasms: results from the EPICOVIDEHA registry 14
Outcome of COVID-19 in allogeneic stem cell transplant recipients: Results from the EPICOVIDEHA registry 13
Age, successive waves, immunization, and mortality in elderly COVID-19 hematological patients: EPICOVIDEHA findings 12
Bloodstream infections due to Gram-negative bacteria in patients with hematologic malignancies: updated epidemiology and risk factors for multidrug-resistant strains in an Italian perspective survey 7
Impact of SARS-CoV-2 vaccination and monoclonal antibodies on outcome post–CD19-directed CAR T-cell therapy: an EPICOVIDEHA survey 6
SARS-CoV-2 Infection In Patients With Mastocytosis: An EPICOVIDEHA Report 6
Totale 905
Salva come PNG Salva come JPEG
Categoria #
all - tutte 6.082
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.082
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202017 0 0 2 0 0 0 4 6 2 3 0 0
2020/202117 0 0 3 4 1 0 4 0 0 0 5 0
2021/2022117 2 0 2 7 6 6 1 14 16 9 20 34
2022/2023384 45 43 24 61 32 44 27 31 44 9 18 6
2023/2024295 12 56 25 19 12 67 30 1 5 10 20 38
2024/202560 15 8 37 0 0 0 0 0 0 0 0 0
Totale 905